Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


BioFocus signs compound management agreement with eMolecules, Inc.

BioFocus, a leading provider of integrated gene-to-clinical candidate drug discovery services and eMolecules, Inc., the creators of the open-access chemical structure search engine, today announced that they have signed a compound management service agreement.  Under the agreement eMolecules has selected Compound Focus, Inc., the BioFocus compound management operation located in South San Francisco, as its preferred partner for client compound order aggregation services.

Clients that order compounds from multiple vendors through the eMolecules platform will have the option to ship their compounds directly from the vendor to the Compound Focus facility where both liquid and solid samples will be reformatted into preferred storage containers, passed through analytical quality control and shipped to an agreed client destination. 

"We are pleased to be the chosen partner of eMolecules as they look to bring the business of compound procurement into the 21st century" said Scott Snyder, Senior Director Compound Focus Inc.  "Compound Focus' full suite of compound management capabilities is well suited to support the broad spectrum of our client requirements" said Klaus Gubernator, CEO of eMolecules.

About BioFocus

BioFocus aims to expand its partners' drug pipelines by accelerating the gene-to-clinical candidate discovery process.  This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry, ADME/PK services, supported by unique chemogenomic and informatics tools, and compound library acquisition, storage and distribution services.  As a service division of Galapagos BioFocus has over 250 employees based in the UK, the US and Switzerland. 

About eMolecules

eMolecules, Inc. has created the world's leading open-access chemical structure search engine at  It has rapidly become the world's most popular chemistry web site, distinguished by fast results, ease of use, and up-to-date information about commercially available chemicals.  eMolecules provides chemistry eCommerce solutions for suppliers of research chemicals and industrial and academic research organizations.  For more information, visit eMolecules,

BioFocus® is a trademarks of Galapagos NV and/or its affiliates © Copyright 2010 Galapagos NV.

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events